CLINICAL_TRIALS
other
· 2026-04-20
Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy [Phase 3]
Summary
Clinical trial update on a Phase 3 study evaluating Samelisant for narcolepsy; status is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suven Life Sciences Limited | Conditions: Narcolepsy | Phase 3 | Status: NOT_YET_RECRUITING